Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,604,096
-$26,245,472 QoQ
Shares Held
572,746
-16.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#124
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $2,466,204,715 across 17 Drug Manufacturers - General names. AZN ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
689,850 | $827,426,853 | |
| 2 | JNJ |
Johnson & Johnson
|
1,608,573 | $408,529,284 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,713,402 | $220,172,157 | |
| 4 | ABBV |
AbbVie Inc.
|
728,959 | $183,435,241 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,034,568 | $130,707,319 | |
| 6 | AMGN |
Amgen Inc
|
343,610 | $124,428,052 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,153,285 | $124,072,280 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
572,746 | $108,604,096 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,604,096 | 572,746 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $134,849,568 | 683,752 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||